349 related articles for article (PubMed ID: 22913896)
1. Hypoglycemic potential of current and emerging pharmacotherapies in type 2 diabetes mellitus.
Brunton SA
Postgrad Med; 2012 Jul; 124(4):74-83. PubMed ID: 22913896
[TBL] [Abstract][Full Text] [Related]
2. Hypoglycemia, treatment discontinuation, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugs.
Bron M; Marynchenko M; Yang H; Yu AP; Wu EQ
Postgrad Med; 2012 Jan; 124(1):124-32. PubMed ID: 22314122
[TBL] [Abstract][Full Text] [Related]
3. Sodium-glucose cotransporter inhibition: therapeutic potential for the treatment of type 2 diabetes mellitus.
Raskin P
Diabetes Metab Res Rev; 2013 Jul; 29(5):347-56. PubMed ID: 23463735
[TBL] [Abstract][Full Text] [Related]
4. Economic burden of hypoglycemia in patients with Type 2 diabetes.
Liu S; Zhao Y; Hempe JM; Fonseca V; Shi L
Expert Rev Pharmacoecon Outcomes Res; 2012 Feb; 12(1):47-51. PubMed ID: 22280196
[TBL] [Abstract][Full Text] [Related]
5. Dipeptidyl peptidase-4 inhibitors in the elderly: more benefits or risks?
Paolisso G; Monami M; Marfella R; Rizzo MR; Mannucci E
Adv Ther; 2012 Mar; 29(3):218-33. PubMed ID: 22411425
[TBL] [Abstract][Full Text] [Related]
6. Hypoglycemia in insulin-treated diabetes: a case for increased vigilance.
Unger J; Parkin C
Postgrad Med; 2011 Jul; 123(4):81-91. PubMed ID: 21680992
[TBL] [Abstract][Full Text] [Related]
7. Lower severe hypoglycemia risk: insulin glargine versus NPH insulin in type 2 diabetes.
Dailey G; Strange P
Am J Manag Care; 2008 Jan; 14(1):25-30. PubMed ID: 18197742
[TBL] [Abstract][Full Text] [Related]
8. [Hypoglycemia in patients with type 2 diabetes mellitus: safe solution of the dangerous problem].
Shestakova MV; Khalimov IuSh
Ter Arkh; 2013; 85(12):144-50. PubMed ID: 24640684
[TBL] [Abstract][Full Text] [Related]
9. Advances in the treatment of type 2 diabetes mellitus.
Israili ZH
Am J Ther; 2011; 18(2):117-52. PubMed ID: 19834322
[TBL] [Abstract][Full Text] [Related]
10. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.
Dailey G
Clin Ther; 2011 Jun; 33(6):665-78. PubMed ID: 21704233
[TBL] [Abstract][Full Text] [Related]
11. [Tight glycemic control in the management of diabetic patients: what has changed since the '90s in the clinical approach?].
Fiorentino TV; Sesti G
G Ital Cardiol (Rome); 2014 Dec; 15(12 Suppl 2):13S-20S. PubMed ID: 25623546
[TBL] [Abstract][Full Text] [Related]
12. Predictors of emergency department and outpatient visits for hypoglycemia in type 2 diabetes: an analysis of a large US administrative claims database.
Simeone JC; Quilliam BJ
Ann Pharmacother; 2012 Feb; 46(2):157-68. PubMed ID: 22234990
[TBL] [Abstract][Full Text] [Related]
13. Probable hypoglycemic adverse drug reaction associated with prickly pear cactus, glipizide, and metformin in a patient with type 2 diabetes mellitus.
Sobieraj DM; Freyer CW
Ann Pharmacother; 2010; 44(7-8):1334-7. PubMed ID: 20516361
[TBL] [Abstract][Full Text] [Related]
14. Balancing risk and benefit with oral hypoglycemic drugs.
Hamnvik OP; McMahon GT
Mt Sinai J Med; 2009 Jun; 76(3):234-43. PubMed ID: 19421967
[TBL] [Abstract][Full Text] [Related]
15. Selecting among ADA/EASD tier 1 and tier 2 treatment options.
McGill JB
J Fam Pract; 2009 Sep; 58(9 Suppl Treating):S26-34. PubMed ID: 19744422
[TBL] [Abstract][Full Text] [Related]
16. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas.
Shorr RI; Ray WA; Daugherty JR; Griffin MR
Arch Intern Med; 1997 Aug 11-25; 157(15):1681-6. PubMed ID: 9250229
[TBL] [Abstract][Full Text] [Related]
17. Minimizing the risk of hypoglycemia in older adults: a focus on long-term care.
Garza H
Consult Pharm; 2009 Jun; 24 Suppl B():18-24. PubMed ID: 19555132
[TBL] [Abstract][Full Text] [Related]
18. [Hypoglycemia--a dreaded complication of diabetes].
Bjørgaas M
Tidsskr Nor Laegeforen; 2000 Aug; 120(20):2441-4. PubMed ID: 11475234
[TBL] [Abstract][Full Text] [Related]
19. [Evaluating the feature of hypoglycemia detected by continuous glucose monitoring system during temporary continuous subcutaneous insulin infusion in type 2 diabetes patients].
Li M; Zhou J; Bo YQ; Lu W; Jia WP; Xiang KS
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(24):1679-82. PubMed ID: 19024537
[TBL] [Abstract][Full Text] [Related]
20. Insulin therapy in elderly patients with type 2 diabetes: the role of insulin glargine.
Janka HU
Diabetes Obes Metab; 2008 Jul; 10 Suppl 2():35-41. PubMed ID: 18577155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
